Beta-adrenergic blockers: Nursing pharmacology
Revisores de contenido
Beta-adrenergic blockers, or just beta blockers, are a group of medications that are mainly used to treat cardiovascular conditions like hypertension, coronary artery disease and its manifestations like angina pectoris and myocardial infarction, as well as heart failure and arrhythmias. Beta blockers can also be used to treat essential tremor, glaucoma, and as prophylactic treatment of migraine attacks.
Now, beta blockers work by blocking beta receptors, of which there are three types, known as beta 1, which are mainly found in the heart and kidneys; beta 2, found in the lung bronchioles as well as the arteries of skeletal muscles; and beta 3, found in adipose tissue. So, beta blockers are classified into two main groups: nonselective and selective. Nonselective beta blockers can block both beta 1 and beta 2 receptors, and include carvedilol, labetalol, nadolol, propranolol, pindolol, and sotalol. On the other hand, selective beta blockers only block beta 1 receptors, and include atenolol, metoprolol, and nebivolol. In addition, carvedilol and labetalol also block alpha-adrenergic receptors found on vascular smooth muscle, which causes vasodilation, or widening of the blood vessels.
Now, another thing to keep in mind is that all beta blockers end in –lol (no joke). Also, they can be administered orally, intravenously, or even via the ophthalmic route.
Once administered, beta blockers block beta receptors, thereby preventing the catecholamines norepinephrine and epinephrine from binding and activating them. As a result, beta blockers decrease the sympathetic nervous system response.
| BETA-ADRENERGIC BLOCKERS | ||
| DRUG NAME | carvedilol (Coreg), labetolol (Trandate), nadolol (Corgard), propranolol (Inderal, InnoPran XL), pindolol (Visken), sotalol (Betapace, Sorine) | atenolol (Tenormin), metoprolol (Lopressor, Toprol XL), nebivolol (Bystolic) |
| CLASS | Nonselective β-blockers | Selective β-blockers |
| MECHANISM OF ACTION | Block β receptors → prevent catecholamines (norepinephrine and epinephrine) from binding and activating them → decrease cardiac contractility, decrease conduction velocity through AV node, decrease heart rate, cardiac output, and blood pressure | |
| INDICATIONS |
| |
| ROUTE(S) OF ADMINISTRATION |
| |
| SIDE EFFECTS |
| |
| CONTRAINDICATIONS AND CAUTIONS |
| |
| NURSING CONSIDERATIONS: BETA-ADRENERGIC BLOCKERS | ||
| ASSESSMENT AND MONITORING |
| |
| CLIENT EDUCATION |
| |
- "Mosby’s 2025 Nursing Drug Reference, 38th edition" Elsevier (2025)
- "Lehne’s Pharmacology for Nursing Care, 12th edition" Elsevier (2026)
- "Karch’s Focus on Nursing Pharmacology, 9th edition" LWW (2023)
- "Pharmacology: A Patient-Centered Nursing Process Approach, 9th edition" Elsevier Canada (2020)
- "Mosby’s 2023 Nursing Drug Reference, 36th edition" Mosby (2022)
- "Saunders Comprehensive Review for the NCLEX-RN, 9th Edition" Saunders (2022)
- "Inappropriate sinus tachycardia: a review" Rev Cardiovasc Med (2021)
- "Beta-blockers for the treatment of arrhythmias: Bisoprolol - a systematic review" Ann Pharm Fr (2022)
Aún no hay notas para este video
Intenta agregar una nota a continuación